首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1847181

美国血栓管理设备市场：市场规模、份额和趋势分析（2025-2031 年）

Clot Management Device Market Size, Share & Trends Analysis | United States | 2025-2031 | Includes: Neurovascular Detachable Coil, Neurovascular Catheter, Neurovascular Guidewire, and 3 more

出版日期: 2025年09月08日 | 出版商:

iData Research Inc. | 英文 165 Pages | 商品交期: 最快1-2个工作天内

价格

如有价格方面的疑问请按下「询问」键来信查询

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

2024年美国血栓管理设备市场价值约28亿美元。预计到2031年，该市场将以3.0%的复合年增长率成长，接近34亿美元。

本报告涵盖神经血管可脱卸弹簧圈、神经血管导管、神经血管导管导引线、神经血管支架、液态栓塞剂及週边经导管栓塞治疗装置。

定量资讯包括销量、平均售价、市场规模、成长率、手术数量和企业市场占有率。

定性资讯包括血管内医院、综合中风中心、办公室实验室和门诊诊所的市场驱动因素和限制因素、併购、产品组合更新和竞争定位。

市场概览

在美国，血栓管理主要有两个应用情境：神经血管介入治疗（着重于动脉瘤治疗）和急性中风介入治疗。

週边血管照护着重于肿瘤栓塞、创伤栓塞和止血，以及老年人和高风险族群血管疾病的治疗。

影像技术和介入方式的进步扩大了可治疗患者的数量，并将许多手术转移到血管内介入治疗，与开放性手术相比，这可以缩短恢復时间。

在脑部，可脱卸弹簧圈和液体栓塞剂能够精确地闭塞动脉瘤。当解剖或病理条件需要持久的支撑结构时，支架可用于血管重组和血流导向。

在周边血管系统中，医师越来越多地使用经导管栓塞治疗装置进行标靶治疗。在许多情况下，导管导引线和导管的改进提高了导航精度，缩短了手术时间，并减少了复杂解剖结构中的併发症。

市场驱动因素

影像技术的进步和早期诊断。脑血管摄影、CT 和 MRI 等技术的广泛应用，提高了未破裂动脉瘤的检出率。早期发现使得较小动脉瘤的治疗成为可能，目前已有的手术器械能够适应更大范围的动脉瘤。

转向血管内治疗。血管通路装置的柔韧性、扭力传递和远端支撑能力都在不断提高。导管导引线更容易操作，微导管也变得更小巧、更容易引导。随着血管通路技术的进步，血管内治疗或将取代外科手术。

新型神经血管技术。新一代可脱卸弹簧圈和液体栓塞剂提高了栓塞的持久性并降低了復发率。神经血管支架采用径向力优化设计，以便更好地适应复杂的解剖结构。腔内支架现已在美国上市，为某些类型的动脉瘤提供了更多临床治疗选择。

外周栓塞术的应用日益广泛。经导管栓塞术受益于更完善的输送系统和新型栓塞剂，目前已应用于肿瘤治疗，并在创伤和出血治疗中发挥越来越重要的作用。

人口因素。随着人口老化，外周支架置入术及相关手术的数量不断增加。糖尿病和肥胖症的流行也增加了对血液透析机通路管理的需求。这些趋势推动了血栓管理装置及相关血管通路技术的持续应用。

市场限制

专业人才有限。训练有素的神经介入专家数量不足以满足所有地区的需求。扩大训练体系需要数年时间，这限制了手术量的成长，并减缓了部分中心设备的供应。

某些手术的疗效不确定性。人们仍担忧不切除病灶的液体栓塞疗法有长期风险。虽然像Onyx这样的产品在特定病例中显示出较高的治癒率，但併发症发生率和手术敏感性仍然指南谨慎使用。

门诊实验室面临定价压力。门诊实验室进行的周边血管手术数量多于医院，采购价格更低。门诊实验室合约竞争激烈。将鞘套、导管导引线和导管与核心器材捆绑销售，加剧了平均售价的压力，并对产品组合单一的门诊实验室构成挑战。

产品组合蚕食。根据动脉瘤类型，颈内动脉支架和先进分流手术的广泛应用可能会导致可剥离弹簧圈和动脉瘤夹的使用量下降。产品规划必须考虑这种混合效应。

采购和报销方面的限制。医疗机构为了应对预算限制和支付方政策，会采用标准化的套件和供应商，这可能导致每个病例使用的器械类型减少，并且在缺乏明确的临床和经济证据的情况下，高端产品的推广速度也会放缓。

目标市场和数据范围

定量分析：市场规模、市场占有率、市场预测、成长率、销售量、平均售价和手术数量。

定性通报：成长趋势、市场限制、竞争分析和主要竞争对手的 SWOT 分析、併购、公司简介和产品系列、FDA 召回（如适用）、颠覆性技术、影响治疗方法方案的疾病概况。

时段：基准年 2024 年，预测期间 2025-2031 年，历史资料 2021-2023 年。

资料来源：对行业领导者的直接访谈、政府医生和手术资料、监管资料、私人医院资料、进出口资料、iData Research 内部资料库。

方法收入模型为单位乘以 ASP，并根据神经血管和周边血管内治疗项目的影像和手术趋势、装置量和设备级采用检验。

目标市场及区隔

可拆卸线圈市场

设备类型：白金裸线圈和涂层铂金线圈。

神经血管导管市场

器械类型：附导线微导管、血流导引微导管、引导管。

按内径进行单位分析：小于 0.05 英寸，大于或等于 0.05 英寸。

依内径分析：小于 1 毫米、1-2 毫米和大于 2 毫米。

依长度分析：小于 100 公分、100 公分至小于 150 公分、150 公分或以上。

神经血管导引线市场

包括微导管和通路系统中使用的导航和支撑配置。

神经血管支架市场

器械类型：常规支架、导流支架、腔内支架。

液态栓塞市场

设备类型：神经血管和周围血管。

经导管栓塞市场

器械类型：颗粒栓塞术、弹簧圈栓塞术、栓塞器栓塞术。

竞争分析

美敦力在液体栓塞领域保持强大的市场份额，在神经血管支架领域展现出领先地位，其血流导向平台继续引领相应类型动脉瘤的治疗。

Stryker 在可剥离弹簧圈和神经血管导引线实力排名第二，并已宣布计划透过收购扩大静脉血栓栓塞症业务，以补充其神经血管业务。

Terumo 在引导管和鞘内液领域占据重要地位，并在神经血管支架领域拥有多个产品系列。

其他製造商也正进军弹簧圈、栓塞剂、入路装置和周边血管栓塞市场。竞争优势体现在产品组合的广度、供货历史、OBL定价策略以及中风和血管内治疗团队支持项目等。

科技与临床趋势

入路与导航：亲水涂层、改进的远端支撑和改进的扭矩响应可缩短手术时间，即使在狭小或弯曲的血管中也能实现更安全的导航。

血流路径改道装置和囊内装置。这些支架旨在实现持久性血管重塑和闭塞。适应症的扩大可能导致某些情况下支架从弹簧圈段移位。

液体栓塞製剂。重点在于提高其渗透性、控制性和操作性，以提高准确性和可靠性。

外周栓塞术。此输送系统具有更好的推送性和稳定性，可支持在肿瘤科、创伤科和止血科的应用。

流程标准化。在中风和血管内治疗领域，正在製定流程规范，以标准化手术包、介入工具和库存，从而减少差异和成本。

护理机构

本报告涵盖医院、综合中风中心、进行择期动脉瘤治疗的社区医院、具备血管内治疗能力的门诊机构以及进行週边血管治疗的诊所实验室。

医疗保健环境的差异会影响产品选择、给药系统偏好、套件标准化和可实现的价格分布。

地区

本报告涵盖美国。

为什么要写这份报告？

美国血栓治疗器材市场中，成长速度最快、潜力最大的领域在哪里？到2031年，弹簧圈、支架、栓塞术、导管、导管导引线和周边栓塞术将各自如何促进市场成长？

血栓管理设备市场与影像处理能力及中风系统准备有何关係？规划应如何反映小动脉瘤检出率的提高和不断发展的急性中风通讯协定？

未来哪些因素将影响市场格局，包括从开放性手术手术转变为血管内手术的转变、诊所实验室的供应策略，以及捆绑式产品对价格和可近性的影响？

与用于动脉瘤治疗的可剥离弹簧圈和手术夹相比，新型囊内支架和血流导向技术的进步将如何影响产品组合？

哪些入路趋势（包括亲水性涂层的作用、远端支撑、微导管内径和长度）对手术时间和结果最为重要？

人口结构变化和透析的兴起将如何影响週边血栓的治疗，以及对栓塞治疗的需求和取得技术产生什么样的影响？

医院采购和院外采购之间预期的平衡点是什么？定价、套件设计和服务协议将如何适应每个管道？

哪些风险可能会减缓成长，包括专家能力有限、报销限制、捆绑协议带来的平均销售价格压力以及对某些液体栓塞手术结果的担忧？

培训和证据评估专案如何在各个客户群中保持价值？

对于医疗服务提供者和供应商而言，实现流程标准化、库存规划以及支援中风预防和周边栓塞计划的最实际步骤是什么？

iData Research 的《美国凝血监测设备市场报告》透过细分和配置模型、企业市场占有率分析、程序和定价详情以及将程序选择与设备需求联繫起来的内容来回答这些问题。

利用这份报告来扩展展品类机会、规划产品蓝图、协调服务计画和供应商限制，并设定定价、合约和库存目标。

Shift toward endovascular treatment. Access devices have improved in flexibility, torque transmission, and distal support. Guidewires are easier to steer and microcatheters are smaller and more navigable, which makes it possible to treat lesions that were difficult to reach in the past. As access improves, endovascular options replace some surgical interventions.

New neurovascular technologies. Next generation detachable coils and liquid embolics improve occlusion durability and reduce recurrence. Neurovascular stents are adopting designs with optimized radial force and better conformability for complex anatomy. Intrasaccular stents are now available in the United States and are expanding clinical choices for select aneurysm types.

Expanding peripheral embolization. Transcatheter embolization devices benefit from better delivery systems and from new embolic materials. Use now spans oncology and is gaining roles in trauma and bleeding management.

Demographic factors. Peripheral stenting and related procedures rise with the aging population. Demand for hemodialysis access management is growing with diabetes prevalence and obesity. These patterns drive steady use of thrombus management devices and associated vascular access technologies.

Market Limiters

Limited specialist capacity. There are not enough trained neurointerventionalists to meet demand in all regions. Training pipelines take years to expand, which constrains procedure growth and slows equipment utilization in some centers.

Outcome uncertainty in specific techniques. Concerns persist about long term risks for some liquid embolic approaches when the nidus is not resected. While products like Onyx have shown higher cure rates in certain cases, complication rates and technique sensitivity still guide cautious adoption.

Price pressure in office based labs. Office based labs perform more peripheral vascular procedures and buy at lower prices than hospitals. Competition for OBL contracts is intense. Bundled offers that combine sheaths, guidewires, and catheters with core devices increase pressure on average selling prices and challenge narrow portfolios.

Portfolio cannibalization. Wider use of intrasaccular stents and advanced flow diversion can shift volumes away from detachable coils and clips in some aneurysm types. Product planning must address this mix effect.

Procurement and reimbursement constraints. Facilities respond to budget limits and payer policies by standardizing kits and vendors. This reduces device variety per case and can slow adoption of premium options without clear clinical and economic evidence.

Market Coverage and Data Scope

Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, average selling prices, and procedure numbers.

Qualitative coverage. Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls where relevant, disruptive technologies, and disease overviews that influence therapy selection.

Time frame. Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2023.

Data sources. Primary interviews with industry leaders, government physician and procedure data, regulatory data, hospital private data, import and export data, and the iData Research internal database.

Method note. Revenue is modeled from units multiplied by ASP and validated against imaging and procedure trends, installed base, and setting level adoption for neurovascular and peripheral endovascular programs.

Markets Covered and Segmentation

Detachable Coil Market

Device type. Bare platinum and coated coils.

Neurovascular Catheter Market

Device type. Over the wire microcatheter, flow directed microcatheter, guiding catheter.

Unit analysis by inner diameter. Less than 0.05 inch and greater than 0.05 inch.

Unit analysis by inner diameter. Less than 1 mm, between 1 and 2 mm, and greater than 2 mm.

Unit analysis by working length. Less than 100 cm, between 100 and 150 cm, and greater than 150 cm.

Neurovascular Guidewire Market

Coverage includes navigation and support profiles used with microcatheters and access systems.

Neurovascular Stent Market

Device type. Traditional stents, flow diversion stents, and intrasaccular stents.

Liquid Embolics Market

Device type. Neurovascular and peripheral vascular.

Transcatheter Embolization Market

Device type. Particle embolization, coil embolization, and plug embolization.

Competitive Analysis

Medtronic remains a leading player with strong share in liquid embolics and leadership in neurovascular stents. Flow diversion platforms continue to define treatment in appropriate aneurysm types.

Stryker ranks second on strength in detachable coils and neurovascular guidewires and has announced plans to expand its venous thromboembolism footprint through acquisition to complement its neurovascular business.

Terumo holds notable positions in guiding catheters and intrasaccular solutions, and participates in neurovascular stents with multiple device families.

Other manufacturers participate across coils, embolics, access devices, and peripheral embolization. Competitive advantage is shaped by portfolio breadth, delivery performance, pricing strategies for OBLs, and support programs for stroke and endovascular teams.

Technology and Practice Trends

Access and navigation. Hydrophilic coatings, refined distal support, and improved torque response reduce procedure time and enable safer navigation in small or tortuous vessels.

Flow diversion and intrasaccular devices. These stents target durable remodeling and occlusion. Wider indication coverage may shift mix away from some coil segments in selected cases.

Liquid embolic formulation. Advances focus on radiopacity, control, and handling to improve precision and confidence.

Peripheral embolization. Delivery systems are improving in pushability and stability, which supports use in oncology, trauma, and bleeding control.

Procedure standardization. Centers are building stroke and endovascular pathways that standardize trays, access tools, and inventory to reduce variation and cost.

Care Settings

The report covers hospitals, comprehensive stroke centers, community hospitals that perform elective aneurysm work, ambulatory sites with endovascular capability, and office based labs that perform peripheral vascular procedures.

Setting differences affect product choice, delivery system preferences, kit standardization, and achievable price corridors.

Geography

This edition covers the United States.

Why This Report

Where is the largest and fastest growing opportunity within the U.S. clot management device market and how do coils, stents, embolics, catheters, guidewires, and peripheral embolization each contribute to growth through 2031.

How does the clot management device market relate to imaging capacity and stroke system readiness, and how should planning account for rising detection of small aneurysms and for evolving acute stroke protocols.

What forces will shape the market going forward, including the shift from open surgery to endovascular treatment, supply strategies for office based labs, and the effect of bundled offerings on price and access.

How will new intrasaccular stents and advances in flow diversion affect product mix relative to detachable coils and to surgical clips for aneurysm management.

Which access trends matter most for case time and outcomes, including the role of hydrophilic coatings, distal support, and microcatheter inner diameter and working length.

How will demographic change and dialysis growth influence peripheral thrombus management and what are the implications for embolization demand and access technology.

What is the expected balance between hospital and OBL purchasing, and how will pricing, kit design, and service contracts adapt to each channel.

What risks could slow growth, including limited specialist capacity, reimbursement constraints, ASP pressure from bundled deals, and outcome concerns in select liquid embolic techniques.

How should commercial teams plan for portfolio cannibalization, where intrasaccular devices and flow diversion may shift units away from coils, and how can training and evidence programs maintain overall account value.

Where are the most practical levers for providers and suppliers, such as pathway standardization, inventory planning, and support for stroke readiness and peripheral embolization programs.

The U.S. clot management device market report from iData Research answers these questions with segment and setting models, company share analysis, procedure and pricing detail, and coverage that links technique choices to device demand.

Use it to size opportunities by category, plan product roadmaps, align service programs with provider constraints, and set targets for pricing, contracting, and inventory.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Competitive Analysis

Emerging Markets And Technologies

Market Trends

Market Developments

Procedure Segmentation

Market Segmentation

Version History

Research Methodology

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

U.S. Clot Management Device Market Overview

3.1 Introduction
- 3.1.1 Interventional Neuroradiology
- 3.1.2 Atherosclerosis
- 3.1.3 Peripheral Arterial Disease (Pad)
3.2 Market Overview & Trend Analysis
3.3 Drivers And Limiters
- 3.3.1 Market Drivers
- 3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers And Acquisitions

Procedure Numbers

4.1 Procedure Analysis And Forecast
- 4.1.1 Neurovascular Detachable Coil Procedures
- 4.1.2 Neurovascular Stent Procedures
- 4.1.3 Liquid Embolic Procedures
- 4.1.4 Peripheral Vascular Transcatheter Embolization Procedures
  - 4.1.4.1.1 Transcatheter Particle Embolization Procedures By Device Type
  - 4.1.4.1.2 Transcatheter Coil Embolization Procedures By Device Type

Detachable Coil Market

5.1 Introduction
5.2 Market Overview
5.3 Market Analysis And Forecast
- 5.3.1 Total Detachable Coil Market
- 5.3.2 Bare Platinum Detachable Coil Market
- 5.3.3 Coated Detachable Coil Market
5.4 Drivers And Limiters
- 5.4.1 Market Drivers
- 5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

Neurovascular Catheter Market

6.1 Introduction
6.2 Market Overview
6.3 Market Analysis And Forecast
- 6.3.1 Over-The-Wire Microcatheter Market
- 6.3.2 Flow-Directed Microcatheter Market
- 6.3.3 Neurovascular Guiding Catheter Market
- 6.3.4 Neurovascular Catheter Market Unit Analysis
  - 6.3.4.1 Neurovascular Catheter Market Unit Analysis By Outer Diameter
  - 6.3.4.2 Neurovascular Catheter Market Unit Analysis By Inner Diameter
  - 6.3.4.3 Neurovascular Catheter Market Unit Analysis By Working Length
6.4 Drivers And Limiters
- 6.4.1 Market Drivers
- 6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

Neurovascular Guidewire Market

7.1 Introduction
7.2 Market Analysis And Forecast
7.3 Drivers And Limiters
- 7.3.1 Market Drivers
- 7.3.2 Market Limiters
7.4 Competitive Market Share Analysis

Neurovascular Stent Market

8.1 Introduction
8.2 Market Overview
8.3 Market Analysis And Forecast
- 8.3.1 Traditional Neurovascular Stent Market
- 8.3.2 Flow Diversion Stent Market
- 8.3.3 Intrasaccular Stent Market
8.4 Drivers And Limiters
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
8.5 Competitive Market Share Analysis

Liquid Embolic Market

9.1 Introduction
9.2 Market Overview
9.3 Market Analysis And Forecast
- 9.3.1 Total Liquid Embolic Market
- 9.3.2 Neurovascular Liquid Embolic Market
- 9.3.3 Peripheral Vascular Liquid Embolic Market
9.4 Drivers And Limiters
- 9.4.1 Market Drivers
- 9.4.2 Market Limiters
9.5 Competitive Market Share Analysis

Transcatheter Embolization Device Market

10.1 Introduction
- 10.1.1 Particle Embolics
- 10.1.2 Coil Embolics
- 10.1.3 Vascular Plugs
10.2 Market Overview
10.3 Market Analysis And Forecast
- 10.3.1 Total Transcatheter Embolization Device Market
- 10.3.2 Total Particle Embolization Market
  - 10.3.2.1 Pva Particle Embolization Market
  - 10.3.2.2 Microsphere Particle Embolization Market
  - 10.3.2.3 Drug-Eluting Particle Embolization Market
  - 10.3.2.4 Radioactive Particle Embolization Market
- 10.3.3 Total Coil Embolization Market
  - 10.3.3.1 Pushable Coil Market
  - 10.3.3.2 Detachable Coil Market
- 10.3.4 Plug Embolization Market
10.4 Drivers And Limiters
- 10.4.1 Market Drivers
- 10.4.2 Market Limiters
10.5 Competitive Market Share Analysis

Abbreviations

简介目录图表

LIST OF CHARTS

Chart 1-1: Clot Management Device Market by Segment, U.S., 2024 - 2031
Chart 1-2: Clot Management Device Market Overview, U.S., 2024 & 2031
Chart 3-1: Clot Management Device Market by Segment, U.S., 2021 - 2031
Chart 3-2: Leading Competitors, Clot Management Device Market, U.S., 2024
Chart 4-1: Clot Management Procedures by Type, U.S., 2021 - 2031
Chart 5-1: Detachable Coil Market by Segment, U.S., 2021 - 2031
Chart 5-2: Leading Competitors, Detachable Coil Market, U.S., 2024
Chart 6-1: Neurovascular Catheter Market by Segment, U.S., 2021 - 2031
Chart 6-2: Leading Competitors, Neurovascular Catheter Market, U.S., 2024
Chart 7-1: Neurovascular Guidewire Market, U.S., 2021 - 2031
Chart 7-2: Leading Competitors, Neurovascular Guidewire Market, U.S., 2024
Chart 8-1: Neurovascular Stent Market by Segment, U.S., 2021 - 2031
Chart 8-2: Leading Competitors, Neurovascular Stent Market, U.S., 2024
Chart 9-1: Liquid Embolic Market by Segment, U.S., 2021 - 2031
Chart 9-2: Leading Competitors, Liquid Embolic Market, U.S., 2024
Chart 10-1: Transcatheter Embolization Device Market by Segment, U.S., 2021 - 2031
Chart 10-2: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2024

LIST OF FIGURES

Figure 1-1: Clot Management Device Market Share Ranking by Segment, U.S., 2024 (1 of 2)
Figure 1-2: Clot Management Device Market Share Ranking by Segment, U.S., 2024 (2 of 2)
Figure 1-3: Companies Researched in This Report, U.S., 2024 (1 of 2)
Figure 1-4: Companies Researched in This Report, U.S., 2024 (2 of 2)
Figure 1-5: Factors Impacting the Clot Management Device Market by Segment, U.S. (1 of 2)
Figure 1-6: Factors Impacting the Clot Management Device Market by Segment, U.S. (2 of 2)
Figure 1-7: Recent Events in the Neurological Device Market, U.S., 2022 - 2025
Figure 1-8: Clot Management Device Procedure Segmentation
Figure 1-9: Clot Management Device Market Segmentation (1 of 2)
Figure 1-10: Clot Management Device Market Segmentation (2 of 2)
Figure 1-11: Version History
Figure 3-1: Clot Management Device Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 2)
Figure 3-2: Clot Management Device Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 2)
Figure 3-3: Leading Competitors, Clot Management Device Market, U.S., 2024 (1 of 2)
Figure 3-4: Leading Competitors, Clot Management Device Market, U.S., 2024 (2 of 2)
Figure 4-1: Clot Management Procedures by Type, U.S., 2021 - 2031
Figure 4-2: Neurovascular Detachable Coil Procedures, U.S., 2021 - 2031
Figure 4-3: Neurovascular Stent Procedures, U.S., 2021 - 2031
Figure 4-4: Liquid Embolic Procedures, U.S., 2021 - 2031
Figure 4-5: Thrombus Management Procedures by Modality, U.S., 2021 - 2031
Figure 4-6: Transcatheter Particle Embolization Procedures by Device Type, U.S., 2021 - 2031
Figure 4-7: Transcatheter Coil Embolization Procedures by Device Type, U.S., 2021 - 2031
Figure 5-1: Detachable Coil Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 5-2: Total Detachable Coil Market, U.S., 2021 - 2031
Figure 5-3: Bare Platinum Detachable Coil Market, U.S., 2021 - 2031
Figure 5-4: Coated Detachable Coil Market, U.S., 2021 - 2031
Figure 5-5: Leading Competitors, Detachable Coil Market, U.S., 2024
Figure 6-1: Neurovascular Catheter Market by Segment, U.S., 2021 - 2031
Figure 6-2: Over-the-Wire Microcatheter Market, U.S., 2021 - 2031
Figure 6-3: Flow-Directed Microcatheter Market, U.S., 2021 - 2031
Figure 6-4: Guiding Catheter Market, U.S., 2021 - 2031
Figure 6-5: Neurovascular Catheter Market Units Analysis by Outer Diameter, U.S., 2021 - 2031
Figure 6-6: Neurovascular Catheter Market Units Analysis by Inner Diameter, U.S., 2021 - 2031
Figure 6-7: Neurovascular Catheter Market Units Analysis by Working Length, U.S., 2021 - 2031
Figure 6-8: Leading Competitors, Neurovascular Catheter Market, U.S., 2024
Figure 7-1: Neurovascular Guidewire Market, U.S., 2021 - 2031
Figure 7-2: Leading Competitors, Neurovascular Guidewire Market, U.S., 2024
Figure 8-1: Neurovascular Stent Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 8-2: Traditional Neurovascular Stent Market, U.S., 2021 - 2031
Figure 8-3: Flow Diversion Stent Market, U.S., 2021 - 2031
Figure 8-4: Intrasaccular Stent Market, U.S., 2021 - 2031
Figure 8-5: Leading Competitors, Neurovascular Stent Market, U.S., 2024
Figure 9-1: Liquid Embolic Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 9-2: Total Liquid Embolic Market, U.S., 2021 - 2031
Figure 9-3: Liquid Embolic Market, U.S., 2021 - 2031
Figure 9-4: Liquid Embolization Market, U.S., 2021 - 2031
Figure 9-5: Leading Competitors, Liquid Embolic Market, U.S., 2024
Figure 10-1: Transcatheter Embolization Device Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-2: Total Transcatheter Embolization Device Market, U.S., 2021 - 2031
Figure 10-3: Particle Embolization Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-4: Total Embolization Particle Market, U.S., 2021 - 2031
Figure 10-5: PVA Particle Embolization Market, U.S., 2021 - 2031
Figure 10-6: Microsphere Particle Embolization Market, U.S., 2021 - 2031
Figure 10-7: Drug-Eluting Particle Embolization Market, U.S., 2021 - 2031
Figure 10-8: Radioactive Particle Embolization Market, U.S., 2021 - 2031
Figure 10-9: Coil Embolization Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-10: Total Coil Embolization Market, U.S., 2021 - 2031
Figure 10-11: Pushable Coil Market, U.S., 2021 - 2031
Figure 10-12: Detachable Coil Market, U.S., 2021 - 2031
Figure 10-13: Plug Embolization Market, U.S., 2021 - 2031
Figure 10-14: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2024
Figure 10-15: Leading Competitors, Particle Embolization Market, U.S., 2024
Figure 10-16: Leading Competitors, Coil Embolization Market, U.S., 2024